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Abstract 
Medical devices with matrix metalloproteinase (MMP)-modulating functionality are 
highly desirable to restore tissue homeostasis in critical inflammation states, such as 
chronic wounds, rotator cuff tears and cancer. The introduction of MMP-modulating 
functionality in such devices is typically achieved via loading of either rapidly-diffusing 
chelating factors, e.g. EDTA, or MMP-cleavable substrates, raising issues in terms of 
non-controllable pharmacokinetics and enzymatic degradability, respectively. Aiming 
to accomplish inherent, long-term, device-induced MMP regulation, this study 
investigated the synthesis of a hydroxamic acid (HA)-methacrylated collagen 
conjugate as the building block of a soluble factor-free MMP-modulating hydrogel 
network with controlled enzymatic degradability. This was realised via a two-step 
synthetic route: (i) type I collagen was functionalised with photonetwork-inducing 
methacrylic anhydride (MA) adducts in the presence of triethylamine (TEA); (ii) this 
methacrylated product was activated with a water-soluble carbodiimide prior to 
reaction with hydroxylamine, resulting in MMP-chelating HA functions. Nearly-
quantitative methacrylation of collagen amines was observed via 2,4,6-
trinitrobenzenesulfonic acid (TNBS) assay; this was key to avoiding intramolecular 
crosslinking side reactions during carbodiimide-mediated activation of collagen 
carboxyl groups. The molar content of HA adducts was indirectly quantified via 
conversion of remaining carboxyl functions into ethylenediamine (EDA), so that 12-16 
mol.% HA was revealed in the conjugate by both TNBS and Ninhydrin assays. 
Resulting UV-cured, HA-bearing collagen hydrogels proved to induce up to ~13 and 
~32 RFU% activity reduction of MMP-9 and MMP-3, respectively, following 4-day 
incubation in vitro, whilst displaying an averaged mass loss in the range of 8-21 wt.%. 
Dichroic and electrophoretic patterns of native type I collagen could still be observed 
following introduction of HA adducts, suggesting preserved triple helix architecture and 
chemical sequence in respective HA-methacrylated collagen conjugate. No hydrogel-
induced toxic response was observed following 4-day culture of G292 cells, whilst 
lower compression modulus and gel content were measured in HA-bearing compared 
to methacrylated hydrogels, likely related to HA radical scavenging activity. The novel 
synthetic strategies described in this work provide a new insight into the systematic 
chemical manipulation of collagen materials aiming at the design of biomimetic, 
inflammation-responsive medical devices.  
 
1. Introduction 
Matrix metalloproteinases (MMPs) are a family of zinc and calcium dependent 
proteinases, which plays a key role in breaking down extracellular matrix (ECM) 
proteins. The levels of MMPs are precisely regulated and are responsible for key 
physiological events such as homeostasis, tissue remodelling, wound healing and 
angiogenesis [1-7]. Together with their beneficial role, numerous clinical studies have 
indicated that the overexpression of MMPs is associated with several inflammatory 
states, such as the ones found in chronic wounds, rotator cuff tears and cancer [8-13]. 
For example, elevated levels of MMPs are found in synovial fluid samples from the 
glenohumeral joints of patients with massive rotator cuff tears [14, 15]. Likewise, 5- to 
10-fold increases in MMP levels were found in chronic leg ulcers compared to acute 
healing wounds; these elevated levels of MMPs explain the turnover in chronic tissue 
and failed wound closure [16-19]. Here, the imbalance between MMPs and tissue 
inhibitors of MMPs (TIMPs) promote constant degradation of neo-tissue and region-
specific growth factors, so that the typical healing process is impaired. In light of the 
critical role MMPs play in maintaining the integrity of tissue ECM, growing research 
has therefore focused on the control of MMP expression aiming to manage 
inflammation and restore physiological homeostasis. 
To date, 26 human MMPs have been found, which can be classified depending on 
the substrate specificity and molecular structure into at least four different classes, i.e. 
stromelysins (MMP-3, -10, -11, -7, -12), collagenases (MMP-1, -8, -13, -18), 
gelatinases (MMP-2 and -9) and membrane types MMPs (MMP-14, -15, -16, -17) [20]. 
MMPs, and especially collagenases, cleave all three α chains of native type I, II and 
III collagens at a covalent bond between the glycine residue and the leucine or 
isoleucine residue, located approximately three-fourths of the way down the molecules 
from the N-terminus [21, 22]. Despite their classification, all MMPs present a catalytic 
zinc-binding domain, as well as a cysteine containing pro-peptide domain at the 
molecular level [23]. The cysteine residue is bound to the zinc atom when the enzyme 
is secreted in its latent conformation (pro-MMP). When the cysteine residue is 
dissociated from the zinc, the active site of the enzyme is exposed, triggering 
proteolytic activity. In vivo, proteolytic removal of the pro-domain for MMP activation is 
mediated by other proteinases, including MMPs, whilst MMP regulation can be further 
achieved by complexation with TIMPs, which block access to the active site [24].  
Aiming to control inflammation-related MMP overexpression via systemic 
administration in vivo, the use of soluble factors has been widely investigated, whereby 
two main research approaches have been pursued:  
(i) Synthesis of new TIMPs to restore physiological MMP/TIMP balance via systemic 
TIMP administration. However, despite several molecules having been synthesised 
and proposed for clinical use as TIMPs over the last 20 years, e.g. [4-(N-
hydroxyamino)-2R-isobutyl-3S-(thiopen-2-ylthiomethyl)-succinyl]-L-phenylalanine-N-
methylamide (Batimastat®) and N-[2,2-dimethyl-1-(methylcarbamoyl)propyl]-2-
[hydroxy-(hydroxycarbamoyl)methyl]-4- methylpentanamide (Marimastat®), their 
clinical translation has been hampered by limited specificity and dose-limiting side 
effects (e.g. musculoskeletal syndrome) following systemic administration [25-27].  
(ii) Application of chelating compounds aiming to revert MMP configuration to the 
native, deactivated state. Chelating agents, such as ethylenediaminetetraacetic acid 
(EDTA), have been proposed as zinc-chelating species to induce complexation with 
the exposed active site and to possess broad range MMP deactivation. Although this 
strategy has been successfully employed in some commercial wound dressings made 
from either hydrolysed collagen (Biostep®), oxidized regenerated cellulose and 
hydrolysed collagen (Promogran®), or a collagen-sodium alginate-
carboxylmethylcellulose composite (ColActive®) [28, 29], challenges with respect to 
the controlled release of the chelating agents and long-term device functionality have 
to date been only partially addressed.  
To avoid unwanted side and temporal effects and to achieve long-lasting MMP 
regulation in situ, the design of multifunctional polymer architectures has received 
growing attention aiming at soluble factor-free, device-based therapies [30, 31]. 
Synthetic polymers, i.e. polyacrylates [32] and respective hydroxamic acid-bearing 
derivatives [26], have been proposed as proof-of-concept anti-MMP substrates, due 
to the presence of ionically-charged and metal-chelating groups, respectively, along 
the polymeric backbone.  
The concept of synthetic polymer-induced MMP complexation and proteolytic 
regulation has been transferred to inherently MMP-cleavable biopolymers, e.g. 
collagen and gelatin, to provide resulting medical devices with an additional biomimetic 
interface. Here, the amino acidic collagen phase of the medical device can act as 
alernative enzymatic substrate. According to this concept, the device-induced uptake 
of MMP-rich biological fluids triggers MMP-induced peptide bond cleavage. In this way, 
the MMP activity can be diverted to the collagen layer and away from the surrounding 
microenvironment, so that homeostasis can be restored. This concept has proved 
promising towards the development of device-based strategies for proteolytic activity 
regulation [33], although the rapid MMP-induced biodegradation may lead to device 
form-instability [34], non-controllable volumetric swelling, and poor mechanical 
properties in vivo, impacting on clinical performance. 
 These challenges have recently been addressed by the development of photo-
curable crosslinking chemistries leading to tunable water-stable collagen networks. 
Photoinduced crosslinking proved key to realise collagen-based biomimetic systems 
with bespoke elasticity [35] and controlled triple helix organisation [36], whereby 
material biocompatibility and wound healing capability have been largely 
demonstrated [37-39]. UV-cured covalent networks made of functionalised collagen 
triple helices have also been presented with integrated MMP-chelating functions, 
whose swelling and compression properties can be controlled in a relatively 
independent fashion, via variation of e.g. type and extent of collagen functionalisation 
[40, 41]. On the other hand, current synthetic routes can only target a small content of 
easily-accessible functional groups, i.e. primary amines, along the collagen backbone, 
resulting in restricted customisation of material functionalities, e.g. with regards to 
MMP-modulation capability. In light of their chemical reactivity and low molar content, 
primary amino terminations of collagen are mainly employed for the generation of 
covalent crosslinks, so that the introduction of MMP-modulating chemical functions in 
resulting covalent networks is challenging to accomplish and control independently of 
the network crosslink density. Furthermore, currently-available crosslinking strategies 
of collagen still raises concerns with regards to the occurrence of irreversible, non-
controllable crosslinking side reactions [43]. Consequently, flexible synthetic routes 
are still to be developed to fully realise multifunctional collagen systems with 
independently-customisable format, properties and functions.  
In this study, we aimed to explore this challenge by building a hydroxamic acid-
methacrylated collagen conjugate as a biomimetic building block for the synthesis of 
UV-cured hydrogel networks with MMP-modulating capability and independently-
regulated crosslink density. Hydroxamic acid (HA) adducts were introduced via 
reaction with hydroxylamine, whereby HA well-known chelating activity was 
hypothesised to serve as means for MMP complexation and deactivation. 
Methacrylate functions were introduced via derivatisation of collagen amino groups to 
prompt the synthesis of a UV-cured crosslinked network in order to achieve enhanced 
enzymatic stability in the resulting materials. In addition to mediating the synthesis of 
the crosslinked network, the derivatisation of collagen with methacrylate functions was 
also exploited to protect the highly reactive, terminal amino groups of (hydroxy-)lysine 
residues to allow for the selective modification of carboxylic functions avoiding either 
irreversible and non-controllable side reactions or time-consuming de-/protection 
work-up.  
Further to the quantification of the degree of collagen methacrylation via 
2,4,6-trinitrobenzenesulfonic acid (TNBS), a new method is proposed to assess 
HA-induced consumption of carboxylic groups via indirect carboxylic acid amination in 
respective methacrylated and HA-conjugated collagen.  
 
2. Materials and methods 
2.1 Materials 
Rat tails were provided by the School of Dentistry, University of Leeds, UK. Type I 
collagen was isolated in-house from the rat tail tendons with acidic treatment [44]. 
Methacrylic anhydride (MA), hydroxylamine hydrochloride (HA), triethylamine (TEA) 
and 2-mecaptoethanol (2-ME) were purchased from Sigma-Aldrich. N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), Ninhydrin and N-
hydroxysuccinimide (NHS) were purchased from Alfa-Aesar. 2-Hydroxy-1-[4-(2-
hydroxyethoxy) phenyl]-2-methylpropan-1-one (I2959) was purchased from 
Fluorochem Limited (Glossop, UK). All the other chemicals were purchased from 
Sigma-Aldrich. 
2.2 Collagen methacrylation 
Methacrylated collagen was prepared as previously reported [40]. Briefly, type I 
collagen from rat tail (CRT) was dissolved (0.25 wt.%) in 17.4 mM acetic acid solution 
and stirred at 4˚C until complete dissolution was obtained. 0.1 M NaOH solution was 
added to achieve a pH of 7.5. MA and TEA were added with a molar ratio of either 25 
or 35 with respect to the molar content of primary amino functions (~ 3 ×10-4 mol·g-1) 
available along the collagen backbone. After 24 hours the reacting mixture was 
precipitated in 10-volume excess of pure ethanol for 8 hours, recovered by 
centrifugation and air dried. 
2.3 Covalent coupling of HA adducts on to methacrylated collagen 
Methacrylated collagen (0.6 wt.%) was vigorously stirred in 0.01 M calcium-free 
phosphate buffer solution (PBS) until complete dissolution. EDC and NHS were added 
to the obtained solution to activate carboxylic acid terminations of collagen 
([EDC]·[COOH]-1= 6; [EDC]=[NHS]; [COOH]= 1 mmol·g-1) [45, 46]. Following 60-min 
activation, an equimolar (to EDC) content of 2-ME was added to quench EDC 
activation. After 10-min reaction, either 2 or 4 molar excess (with respect to collagen 
carboxyl functions) of hydroxylamine chloride was added to induce HA covalent 
coupling. After 24-hour reaction, the mixture was precipitated in 10-volume excess of 
pure ethanol for 8 hours and recovered by centrifugation. This process was repeated 
twice and the collagen precipitate air dried.  
2.4 Grafting of collagen carboxyl groups with ethylene diamine 
Methacrylated and respective HA-conjugated collagens were aminated with 
ethylene diamine (EDA). This was carried out to indirectly quantify (via TNBS and 
Ninhydrin) the degree of HA-mediated collagen functionalisation by measuring 
HA-induced consumption of collagen carboxylic groups. Either methacrylated or 
HA-conjugated collagen (0.6 wt.%) was vigorously stirred in 0.01 M calcium-free PBS 
and 17.4 mM acetic acid, respectively, until complete dissolution. EDC and NHS 
([EDC]·[COOH]-1= 6 mmol·g-1; [EDC]=[NHS]) were added and each solution stirred for 
one hour before adding an equimolar EDC content of 2-ME. After 10 minutes, 50 molar 
excess of EDA was added. This allowed for the grafting of EDA on to activated 
carboxyl groups of either methacrylated or HA-conjugated collagen, resulting in the 
introduction of, and the conversion of carboxyl functions to, terminal amino groups. 
Following 24-hour reaction, reacting solutions were precipitated in 10-volume excess 
of pure ethanol for 8 hours and recovered by centrifugation. Retrieved products were 
re-dissolved in either PBS or 17.4 mM acetic acid, and precipitated again prior to air 
drying.   
2.5 (2,4,6)-Trinitrobenzenesulfonic acid (TNBS) and Ninhydrin assays 
The TNBS assay was used to directly measure derivatisation of amino groups and 
to indirectly measure derivatisation of carboxyl groups into either methacrylate, EDA 
or HA groups, and also respective collagen functionalisation. Briefly, 11 mg of dry 
samples were mixed with 1 mL of 4 wt.% NaHCO3 (pH 8.5) and 1 mL of 0.5 wt.% 
TNBS solution at 40 °C under mild shaking. After 4-hour reaction, 3 mL of 6 M HCL 
solution was added and the overall reacting mixture incubated at 60°C for one hour to 
dissolve any sample residues. The solution was then cooled to room temperature, 
mixed with 5 mL distilled water, and extracted three times with 15 mL diethyl ether to 
remove non-reacted TNBS reagent. All samples were read against a blank (not 
containing samples) with an UV-Vis spectrophotometer (Model 6305, Jenway) at 346 
nm, the content of free amino groups and degree of crosslinking (F) were calculated 
according to equations 1 and 2, respectively, as follows:  !"#(%&'))(*"##+),-) = /	×	23'(456-!)×	7.7/9.56×97:	×	3	×	;                                                           (Eq. 1) 𝐹 = 100 −	@AB(CDE)FGHIJ.@AB	(CDE)IKLL. 	× 	100                                               (Eq. 2) 
where Abs (346nm) is the UV absorbance value recorded at 346 nm, 2 is the dilution 
factor, 0.02 is the volume of sample solution (in litres), 1.46×104 is the molar absorption 
coefficient for 2,4,6-trinitrophenyl lysine (in M-1·cm-1), b is the cell path length (1 cm), 
x is the dry sample weight, whilst mol(Lys)coll and mol(Lys)funct. represent the total molar 
content of free amino groups in native and functionalised collagen, respectively. (Lys) 
is hereby used to recognise that lysines make the highest contribution to the molar 
content of collagen free amino groups, although contributions from hydroxylysines and 
amino termini are also taken into account.  
The Ninhydrin assay was further used to confirm the degree of derivatisation of the 
collagen amino groups previously-obtained via TNBS. 11 mg of dry sample were 
mixed with 4 mL distilled water and 1 mL of 8 wt.% Ninhydrin solution in acetone. The 
mixture was then incubated at 100 °C for 15 min. To terminate the reaction, the mixture 
was cooled on ice and 1 mL of 50 % (w/v) ethanol was added. The amount of free 
amino groups was determined by reading the absorbance at 570 nm against a blank 
sample (UV-Vis, Model 6305, Jenway). A standard calibration curve was prepared by 
carrying out above-mentioned assay with known mass of collagen. Three replicates 
were used for both TNBS and Ninhydrin measurements. Data are presented as 
mean±SD. 
2.6 UV-induced hydrogel formation 
Methacrylated collagen and respective HA-conjugated products were dissolved (1.2 
wt.%) in 0.01 M calcium-free PBS containing 1 wt.% 2-Hydroxy-4’-(2-hydroxyethoxy)-
2-methylpropiophenone (I2959) photoinitiator. The solution was centrifuged at 3000 
rpm to remove any air bubbles, followed by casting (600 µL·well-1) on to a 24-well plate 
(Corning Costar) and UV curing (Spectroline, 346 nm) for 30 mins at each side of the 
dish. Formed hydrogels were rinsed with distilled water, dehydrated via ascending 
series of ethanol solutions and air dried.  
2.7 Quantification of gel content 
The gel content was measured to investigate the overall portion of the covalent 
hydrogel network insoluble in 17.4 mM acetic acid solution [47]. Dry collagen networks 
(md: 0.01 – 0.02 g) were individually incubated in 2 mL of 17.4 mM acetic acid solution 
for 24 hours. Resulting samples were further air dried and weighed. The gel content 
(G) was calculated by the following equation: 𝐺 = @N@O × 100                                                                               (Eq. 3)     
where m1 is the dry mass after the incubation. Three replicates were used and the data 
are presented as mean±SD.  
2.8 Compression tests 
Air-dried UV-cured samples were equilibrated in PBS via overnight incubation at 
room temperature. Resulting PBS-equilibrated hydrogel discs (Ø: 18 mm; h: 5-6 mm) 
were compressed at room temperature with a compression rate of 3 mm·min-1 (Instron 
ElectroPuls E3000). A 250 N load cell was operated up to complete sample 
compression. Stress–strain curves were recorded and the compression modulus 
quantified as the slope of the plot linear region at 25–30% strain. Three replicates were 
employed for each collagen network composition. Data are presented as mean±SD.  
2.9 MMP activity and enzymatic degradation study 
Full-length human pro-MMP-3 (PF063, Merck Millipore, UK) and pro-MMP-9 
(PF038, Merck Millipore, UK) were activated in TCNB buffer containing 50 mM Tris, 
10 mM CaCl2, 150 mM NaCl and 0.05% Brij-23 (w/v), pH 7.5) in the presence of p-
aminophenyl mercuric acetate (AMPA) with a final concentration of 1 mM at 37°C for 
24 hours and 2 hours respectively, according to manufacturer’s guidance. Dry collagen 
networks (n=4) were individually placed in a 24-well plate containing activated 
solutions of either MMP-3 or MMP-9; the plate was then incubated at 37°C on a 
benchtop orbital shaker for up to 4 days. The concentration of activated MMPs was 60 
ng·mL-1 and was selected according to the MMP concentration found in either torn 
rotator cuff or chronic wound fluid [8]. Sample-free solution controls of either activated 
or non-activated MMPs were used as control. A standard commercial assay (Abcam, 
ab112146) was used to detect the MMP activity in the supernatants; additionally, the 
MMP-incubated samples were collected, dehydrated with increasing distilled 
water/ethanol series (0, 25, 50, 80 and 100 vol.% ethanol) and air-dried. The mass of 
the retrieved dried samples was measured (m4, n=4) and the relative mass loss 
calculated as the equation shown below: 𝜇QRB = @:@O × 100                                                                                               (Eq. 4)  
2.10 Circular dichroism  
Circular dichroism (CD) spectra of native and functionalised samples were acquired 
with a Chirascan CD spectrometer (Applied Photophysics Ltd) using 0.2 mg·mL-1 
solutions in 17.4 mM acetic acid or 0.01 M PBS solution. Sample solutions (n=2) were 
collected in quartz cells of 1.0 mm path length, whereby CD spectra were obtained 
with 2.0 nm band width and 20 nm·min-1 scanning speed. A spectrum of the 17.4 mM 
acetic acid control solution was subtracted from each sample spectrum. 	𝜃@QT,V 	= WXY×Z[			97×\×]                                                                        (Eq.5) 
where θλ is the observed molar ellipticity (degrees) at wavelength λ, d is the path length 
and c is the concentration (0.2 mg·mL-1). MRW is the mean residue weight and equals 
to 91 g·mol-1 for amino acids [48].  
2.11 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
The samples were dissolved (1 wt.%) in SDS sample buffer containing 160 mM 
Tris-HCl (pH 6.8), 2% SDS, 26% glycerol, and 0.1% bromophenol blue. Sample 
solutions were heated for 60 seconds at 90 ˚C. 30 µL of each sample solution were 
added onto 4% stacking gel wells and separated on 15% resolving gels (200 V, 45 
min). Protein bands were visualized after 60 min staining (0.1 wt.% Comassie Blue, 
12.5 vol.-% trichloroacetic acid) and 60 min treatment in water under mild shaking. 
The molecular weight of resulting bands was approximately by measuring the relative 
mobility of the standard protein molecular weight markers. 
2.12 Cell culture 
Cells from the G292 cell line were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM), supplemented with 10% fetal bovine serum (FBS), 1% glutamine, and 2.5 
mg mL-1 penicillin-streptomycin, in a humidified incubator at 37 ˚C and 5% CO2. Cells 
were passaged every 3 days with 0.25% trypsin/0.02% EDTA. Freshly-synthesised, 
UV-cured hydrogel samples were incubated in a 70 vol.% ethanol solution under UV 
light. Retrieved samples were washed in PBS three times, prior to cell seeding. G292 
cells (8×103 cells∙ml-1) were seeded on top of the hydrogel (following UV disinfection) 
and incubated at 37 ˚C for 4 days. After incubation, the hydrogels (n=6) were washed 
with PBS (x 3) and transferred to a new 24-well plate before adding the dying agent of 
Calcein AM and Ethidium homodimer-1; the plate was then incubated for 20 minutes 
away from light. Finally, live and dead stained hydrogels were placed on to a glass 
slide for fluorescence microscopy imaging (Leica DMI6000 B). Control cells were 
cultured on tissue culture plastic (negative) and killed by 30 min-incubation in 70 vol.% 
methanol (positive). Other than live /dead staining, cell viability was assessed using 
Alamar Blue assay (ThermoFisher Scientific, UK) according to manufacturer’s 
guidance. 
2.13 Statistical analysis 
Statistical analysis was carried out using OriginPro 8.5.1. Significance of difference 
was determined by one-way ANOVA and post-hoc Tukey test. A p value of less than 
0.05 was considered to be significant different. Data are presented as mean ± SD. 
3. Results and discussion 
In the following, the design of a HA-methacrylated collagen conjugate will be 
presented as a building block for a biomimetic medical device with integrated 
MMP-modulating capability. The medical device is realised at the molecular scale via 
the synthesis of a UV-cured hydrogel network of methacrylated collagen triple helices, 
in which MMP-modulating capability is achieved via introduction of HA adducts to 
carboxyl groups of methacrylated collagen.  
Sample nomenclature used in this work is as follows: methacrylated and respective 
HA-conjugated collagen precursors are coded as ‘MAXX’ and ‘HAYY’, respectively, 
whereby ‘MA’ and ‘HA’ indicate the type of collagen adduct; whilst ‘XX’ and ‘YY’ 
describe the molar ratios of respective monomer in the functionalisation reaction. EDA-
reacted samples were coded as either ‘MAXX-EDA’ or ‘HAYY-EDA’, respectively. 
Collagen networks are coded as either ‘MAXX*’ or ‘HAYY*’, whereby ‘*’ identifies the 
chemically-crosslinked state, whilst the other labels have the same meaning as 
previously-mentioned.   
 
Scheme 1. Design of a soluble factor-free collagen system with integrated MMP-modulating capability. 
(I): Type I collagen is functionalised with MA with nearly-quantitative derivatisation of primary amino 
groups. (II): Retrieved product is reacted with hydroxylamine following carbodiimide-induced activation 
of collagen carboxylic groups, resulting in a photo-active collagen-HA conjugate with integrated MMP-
chelating capability (III). (IV): UV irradiation in the presence of I2959 successfully leads to photo-induced 
crosslinking (—) of collagen triple helices ( ) bearing MMP-chelating HA adducts ( ).  
 
3.1 Synthesis of HA-methacrylated collagen conjugate  
The TEA-catalysed reaction of MA with collagen proceeds via an amine-initiated 
nucleophilic addition/elimination mechanism and was therefore carried out prior to 
coupling with HA. This reaction with MA was exploited for two purposes (Scheme 1): 
(i) to introduce photoactive functions on to free amino terminations of collagen, e.g. 
(hydroxy-)lysines and amino termini, responsible for the subsequent formation of a 
hydrogel network [36, 40]; (ii) to protect highly-reactive amino terminations prior to 
selective derivatisation of carboxyl into MMP-chelating functional groups, so that intra-
crosslinking side reactions could be minimised.  
MA-mediated functionalisation of collagen was confirmed via TNBS and the content 
of MA adducts proved to be controlled depending on MA/Lys molar ration selected 
during the reaction (Table 1). TNBS assay of MA-reacted collagen samples revealed 
nearly-quantitative and reproducible consumption of primary amino groups, so that an 
averaged degree of functionalisation higher than 80 mol.% was observed (FMA: 82 – 
100 mol.%). Similar reactions have been described in the literature [40, 49, 50], 
although resulted in lower FMA values, suggesting that identified experimental 
conditions were crucial for the above findings. Although an FMA value of 100 mol.% 
was recorded in sample MA35, longer solubilisation time was required with respect to 
sample MA25 (FMA: 94 mol.%); consequently, the latter product was selected for future 
investigations. 
Table 1. Averaged degree of methacrylation (FMA) determined via TNBS assay of collagen products 
(n=3) obtained with selected MA/Lys molar ration.  
Sample ID [MA][Lys]-1 FMA /mol% 
MA10 10 82 ± 2 
MA25 25 94 ± 1 
MA35 35 100 ± 0 
 
To achieve the HA-methacrylated collagen conjugate, carbodiimide-induced 
activation of sample MA25 was pursued in PBS, due to the limited solubility of collagen 
triple helices in organic solvents. Introduction of EDC and NHS in collagen solutions 
is known to induce crosslinking reaction between collagen amino groups and NHS-
activated collagen carboxylic groups, resulting in the formation of a gel [51]. In 
agreement with previously-discussed TNBS results, solution gelation was not 
observed in our case, providing evidence that minimal unwanted intra-crosslinking 
reaction occurred between residual amino groups and activated carboxyl groups of 
collagen. At the same time, solubilisation of retrieved, HA-reacted collagen product in 
an aqueous solution containing I2959 promptly led to the formation of a UV-cured 
hydrogel, as expected in light of the activation of covalently-coupled MA functions. 
 
3.2 Quantification of HA-mediated functionalisation via an indirect amination 
strategy 
Following reaction with HA and confirmation of UV-induced gelation, attention 
moved to the direct quantification of HA-mediated functionalisation in 
HA-methacrylated collagen samples. HA was covalently coupled to carboxylic acids 
of collagen, so that no direct colorimetric assay, i.e. TNBS or Ninhydrin, could be 
carried out with the resulting product. Kenawy et al. reported on the functionalisation 
of poly(N-acryloxysuccinimide) with HA, whereby resulting poly(N-hydroxyacrylamide) 
was successfully analysed via FTIR spectroscopy and 1H-NMR [52]. However, in the 
case of FTIR, the broad HA-related peaks at 3230 and 3480 cm-1 (due to NH and OH 
bonds) overlap with the ones related to the stretching vibrations of collagen NH bonds. 
Likewise, HA-related 1H-NMR signals at d  3.0 (singlet, OH) and d 4.10 ppm (singlet, 
NH) are likely to overlap with the ones of the main collagen amino acids, e.g. proline. 
Consequently, assessment of HA content in HA-reacted collagen products can only 
be qualitative when using the above-mentioned methods. 
In order to overcome this challenge, we aimed to indirectly quantify the molar 
content of HA by assessing the molar content of collagen carboxyl groups prior to and 
following reaction with HA, since the carboxyl groups in collagen were directly involved 
in the coupling reaction. To reach this goal, derivatisation of collagen carboxyl groups 
into TNBS- and Ninhydrin-detectable terminal amino groups was pursued in both 
methacrylated and HA-reacted collagen products via reaction with EDA (Scheme 2).  
To avoid unwanted crosslinking reaction and promote selective grafting of EDA 
molecules, samples MA25, HA2 and HA4 were reacted with a 50-molar excess of EDA 
following carboxyl function activation with EDC/NHS. No gel formation was observed 
during the EDC-mediated activation of collagen and following reaction of EDC-
activated collagen with EDA. These observations provided evidence that an EDA-
grafted rather than crosslinked product was obtained, supporting the validity of the 
proposed approach in selectively derivitising carboxylic acids into terminal amines. 
Table 2 reports values related to the molar content of EDA- and HA-related adducts, 
as well as respective degrees of HA-mediated collagen functionalisation (FHA). 
 
Scheme 2. Quantification of carboxyl terminations of collagen via an indirect amination strategy. 
Methacrylated collagen (I) was carbodiimide-activated and grafted with EDA, resulting in the direct 
conversion of carboxyl to primary amino functions (II). The aminated product was assessed with TNBS 
(III), allowing for the indirect quantification of pristine carboxyl functions via UV-Vis spectroscopy (IV).  
 
EDA-induced grafting was confirmed by the fact that an increased content of free 
amino groups was recorded in sample MA25-EDA ([R-NH2]: 1.80·10-4 mol·g-1) with 
respect to the one measured in sample MA25 ([Lys]: 0.19·10-4 mmol·g-1), so that an 
overall grafted EDA content of 1.61·10-4 mol·g-1 was successfully achieved. Most 
importantly, the molar content of amino groups was found to be lower in both HA-
conjugated products, i.e. samples HA2-EDA ([EDA]: 0.14·10-4 mol·g-1) and HA4-EDA 
([EDA]: 0.06·10-4 mol·g-1).  
These results confirm the successful coupling of HA adducts on to collagen carboxyl 
functions. Considering an overall amount of carboxylic acids of 1×10-3 mol·g-1 in rat 
tail collagen [43, 44], above-mentioned results corresponded to an averaged degree 
of HA-mediated functionalisation of up to ~16 mol.% (Table 2). Together with TNBS, 
Ninhydrin assay was also carried out to further confirm the above findings. Also in this 
case, a decreased molar content of amino groups was recorded in HA-conjugated 
compared to methacrylated collagen samples. An averaged FHA value of up to ~14 
mol.% was obtained, well in line with previous TNBS data.  
 
Table 2. Degree of HA-mediated functionalisation (FHA) determined in EDA-reacted, methacrylated, and 
respective HA-conjugated samples (n=3) via both TNBS and Ninhydrin assays. EDA terminal amino 
groups were used to indirectly quantify the consumption of carboxyl groups and consequent coupling 
of HA adducts. n.a.: not applicable. 
Sample ID 
[EDA] /mol·g-1 (×10-4) [HA] /mol·g-1 (×10-4) FHA /mol.% (*) 
TNBS Ninhydrin TNBS Ninhydrin TNBS Ninhydrin 
MA25-EDA 1.61±0.08 1.48±0.05 n.a. n.a. n.a. n.a. 
HA2-EDA 0.14±0.04 0.17±0.03 1.47±0.04 1.21±0.08 14.7±0.4 12.1±0.7 
HA4-EDA 0.06±0.02 0.09±0.04 1.55±0.06 1.37±0.09 15.5±0.6 13.7±0.9 
(*) FHA was determined according to an overall content of collagen carboxyl groups of 1×10-3 mol·g-1 [53, 
54]. 
 
Results obtained via collagen amination and colorimetric assays therefore provided 
supporting evidence that covalent coupling of both methacrylate and HA adducts could 
be selectively accomplished by independently targeting collagen amino and carboxyl 
groups, respectively. The nearly-quantitative lysine functionalisation with MA adducts 
proved key to selectively target free carboxyl functions of methacrylated collagen in a 
controlled fashion. The presented synthetic approach proved therefore proved reliable 
to enable the quantification of free carboxylic groups avoiding either the occurrence of 
well-reported, undesired intramolecular crosslinking reactions between collagen 
amino and carboxyl functions, or the employment of time-consuming de-/protection 
work-up [53, 55-57]. Although low variation in HA coupling was measured by both 
TNBS and Ninhydrin assays, a significant effect on the MMP-modulating capability of 
resulting UV-cured hydrogels was observed (section 3.4). It is expected that a wider 
range of functionalisation can be obtained by further adjusting the molar ratio of 
hydroxylamine with respect to carboxylic acid groups of methacrylated collagen.  
 
3.3 Analysis of collagen conformation 
SDS-PAGE was used to both elucidate the chemical composition of reacted 
products and to explore the triple helix organisation of methacrylated and 
HA-conjugated products. Retention of the triple helix architecture of collagen is key to 
enable resulting materials with chemotactic functionality, enhanced mechanical 
properties and decreased swellability [39]. Although we previously confirmed that 
collagen methacrylation had minimal effect on the collagen triple helix structure [40], 
the reaction of collagen-based polypetides with hydroxylamine has been reported to 
catalyse the chemical cleavage of peptide bonds between asparagine and glycine 
residues [58-60], which is likely to induce a denaturation of collagen triple helices. 
Despite the low (up to 9 mM) hydroxylamine concentrations employed in this study, it 
was important to confirm that no degradation product was formed in reacted species, 
aiming not to compromise chemical sequence and organisation of native collagen.  
In-house extracted type I rat tail collagen was confirmed to display electrophoretic 
bands of monomeric a-chains (~100 kDa) and dimeric b-components (~200 kDa), as 
shown in Figure 1 (A). Each of these bands was observed in the electrophoretic 
patterns of samples MA25, HA2 and HA4, whilst no further band could be identified. 
SDS-PAGE data therefore supported the fact that no detectable collagen degradation 
occurred during the reaction with hydroxylamine. The minimal pattern variation in the 
electrophoretic reference bands associated with reacted, with respect to, native 
collagen, also suggested no alteration to the native triple helix organisation following 
collagen functionalisation.  
 
Figure 1. (A): SDS-PAGE analysis of standard (S), in-house isolated type I collagen from rat tail (CRT), 
as well as samples of MA25, HA2 and HA4. (B): Far-UV CD spectra (n=2) of samples of collagen (black 
solid line, RPN ~0.122), MA25 (black dash line, RPN ~0.113), HA2 (black dash and dot, RPN 
~0.094), HA4 (black dot, RPN ~0.101) and gelatin (grey).  
 
To further elucidate this point, CD spectroscopy was carried out. Collagen presents 
a unique CD spectrum with a negative peak at 197 nm and a positive peak at 221 nm 
[36, 61, 62]; these characteristic peaks could be identified in all collagen samples 
(Figure 1 B), confirming the presence of polyproline-II and triple helices, respectively 
[63]. The magnitude ratio of positive to negative peak RPN) in the CD spectra provides 
an indication of the content of collagen triple helices [40]. The RPN values measured 
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in the CD spectra of samples MA25, HA2 and HA4 were 0.113, 0.094 and 0.101, 
respectively, which were only slightly lower than the RPN value measured in the CD 
spectra of native collagen (RPN: 0.122). By normalising the RPN value measured from 
functionalised samples with respect to the one of native collagen, a degree of triple 
helix preservation of at least 77 RPN% is observed. These results provide supporting 
evidence that collagen triple helices could still be preserved in HA-conjugated collagen 
samples, although at lower extent with respect to the case of methacrylated samples.  
The preservation of collagen triple helices in HA-conjugated collagen is an 
interesting finding, given that additional HA, besides MA, adducts are covalently 
coupled to the collagen backbone. This finding may be explained by the fact that the 
overall HA molar content was limited up to only 16 mol.% of collagen carboxyl 
functions, suggesting that increasing the degree of HA-mediated functionalisation may 
negatively affect the triple helix organisation of native collagen.   
 
3.4 Hydrogel impact on MMP activities and related enzymatic degradability 
Following elucidation of the molecular architecture, protein organisation, and 
UV-cured network formation, hydrogel proteolytic degradability and MMP-regulation 
capability were studied in vitro with either MMP-3 or MMP-9. Both MMPs were 
selected in light of their documented overexpression in inflammation states, such as 
in the case of rotator cuff tear [5], chronic wounds [3, 9] and osteoarthritis [64]. Figure 
2 (A) reports the MMP-3 activity of aqueous media following 4-day conditioning with 
samples MA25*, HA2* and HA4*, with respect to sample-free MMP-3 solutions.  
     
Figure 2. (A): MMP-3 activity measured in vitro following 4-day incubation with either no sample (MMP-
3) or samples of MA25*, HA2* and HA4*. Results are normalised to the MMP-3 activity recorded in 
sample-free medium. (B): Relative mass of samples of CRT, MA25*, HA2* and HA4* following 4-day 
incubation in MMP-3-containing aqueous solution (60 ng·mL-1 MMP-3). *p<0.05, **p<0.01 and 
***p<0.001 are considered significant (n=4). 
All samples proved to induce a significant reduction in MMP-3 activity (p<0.001), with 
samples HA2* (MMP-3: 81±4 RFU%) and HA4 (MMP-3: 70±6 RFU%) displaying 
significantly higher effect (p<0.01) with respect to methacrylated hydrogels (MMP-3: 
87±2 RFU%). Together with analysis on supernatants, the relative mass of 4-day 
incubated samples was measured and compared to that of a control sample of native, 
non-crosslinked CRT (Figure 2 B). Hydrogel HA4* proved to show the highest relative 
mass (µrel: 96±2 wt.%), which was significantly higher than the ones recorded in 
samples HA2* (µrel: 79±4 wt.%) and MA25* (µrel: 79±3 wt.%). As expected, the lowest 
relative mass was found in the control sample (µrel: 44±4 wt.%), due to the absence of 
a crosslinked network at the molecular scale. 
Similar trends were confirmed following sample incubation with MMP-9-containing 
aqueous media (Figure 3 A). MMP-9 activities were found to be reduced to either 88±5 
or 87±4 RFU% following supernatant conditioning with either sample of HA2* or HA4*, 
with significant difference observed in comparison to supernatant treated with sample 
MA25* (MMP-9: 98±1 RFU%). As observed with MMP-3, sample CRT exhibits the 
lowest relative mass (µrel: 57±7 wt.%), whilst both MMP-chelating hydrogels displayed 
more than 90 wt.% averaged relative mass (Figure 3 B). In comparison, sample MA25* 
displayed a lower relative mass (µrel: 87±3 wt.%), which proved significantly different 
with respect to the ones of all crosslinked samples.  
       
Figure 3. (A): MMP-9 activity measured in vitro following 4-day incubation with either no sample (MMP-
9) or samples of MA25*, HA2* and HA4*. Results are normalised to the MMP-9 activity recorded in 
sample-free medium. (B): Relative mass of samples of CRT, MA25*, HA2* and HA4*, following 4-day 
incubation in MMP-9-containing aqueous solution (60 ng·mL-1 MMP-9). *p<0.05, **p<0.01 and 
***p<0.001 are considered significant (n=4). 
 
MMP-3 and MMP-9 belong to two different classes of MMPs, namely stromelysins 
and gelatinases, respectively. Accordingly, MMP-3 presents broad substrate 
specificity and induces the activation of collagenases, e.g. MMP-1, a potent collagen-
degrading enzyme. In contrast, MMP-9 is reported to preferentially degrade denatured 
collagen, i.e. gelatin, rather than collagen triple helices [65]. Our gravimetric data 
support the broader substrate specificity presented by MMP-3, whereby lower relative 
mass was recorded in both native collagen and hydrogel samples following incubation 
with MMP-3, compared to the case of the MMP-9–incubated samples. The broad 
specificity of MMP-3 compared to MMP-9 was also reflected by the higher hydrogel-
induced activity reduction of the former compared to the latter enzyme. In light of 
MMP-9 specificity towards single rather than triple helices of collagen, above-
mentioned observations provide further indirect evidence of triple helix retention in 
both methacrylated and HA-conjugated collagen hydrogels. The non-preferential 
specificity of MMP-9 towards collagen triple helices was also in agreement with the 
insignificantly different MMP-9 activity (Figure 3 A) and relative sample mass (Figure 
3 B) recorded following 4-day incubation with either sample HA4* or sample HA2*, 
despite the increased HA content measured in the former compared to the latter 
system (Table 2). This observation correlated with previously-reported CD spectra 
(Figure 1 B), which indicated an increased triple helix-related RPN value in spectra of 
sample HA4 (RPN: 0.101), with respect to the case of sample HA2 (RPN: 0.094). 
Other than MMP-9, the fact that obtained hydrogel samples promoted increased 
deactivation of MMP-3 may be beneficial to control the excessive activation of tissue-
detrimental collagenases [24]. Overall, above-mentioned proteolytic and gravimetric 
results with both MMP-3 and MMP-9 demonstrated the MMP-modulating capability 
induced by the functionalisation of the collagen backbone with MMP-chelating HA 
adducts. In contrast to endogenous MMP inhibitors, the HA-conjugated collagen 
hydrogels obtained in this study induce proteolytic modulation by binding to the active 
Zn site and a non-active Ca site inducing the MMP to adapt its native conformation.  
Until now, there has been limited study on targeting the overexpression of MMPs 
due to the undesired side effects associated with the administration of soluble MMP 
inhibitors. Although HA-conjugated synthetic polymer systems have been presented 
in the past, no collagen variant has yet been developed, likely related to the challenges 
associated with the control and manipulation of the collagen architecture and the 
occurrence of crosslinking side reactions during collagen modification. Skarja et al. 
reported HA-containing microspheres prepared via derivatisation of poly(methyl 
methacrylate-co-methacrylic acid) and respective microsphere-induced reduction of 
the activity of MMP-2, -3, -8 and -13 [26]. Other studies investigated the effect of ovine-
based collagen dressing on a broad spectrum of MMPs reduction but led to undesired 
clinical outcomes [66-69]. Layer by layer SiRNA coated nylon bandage was reported 
to yield rapid chronic wound closure in a diabetic mice model silencing 60% of MMP-9 
activity in a two week study [70]; however, the biocompatibility of nylon may need to 
be considered further to enable the clinical applicability of a resulting device.  
We have recently reported a 4VBC-functionalised collagen hydrogel with 
covalently-bound electron rich aromatic adducts, such that MMP-9 activity was 
reduced by 50% in 4 days in vitro [38]. With respect to that study, the hereby presented 
HA-conjugated formulation is likely to offer additional advantages, given the possibility 
to control the MMP-modulating capability independently of the crosslink density of the 
network.  
 
3.5 Characterisation of physical properties  
Once the MMP-modulating functionality of HA-bearing hydrogels was addressed, 
attention moved to the physical characterisation of the hydrogels. Gel content was 
quantified gravimetrically to gain information on the crosslink density and overall 
portion of non-extractable crosslinked material (Figure 4 A). Methacrylated hydrogels 
MA25* revealed the highest gel content of over 90 wt.% (G: 93±1 wt.%), which was 
higher than the one measured with samples HA2* (G: 87±1 wt.%) and HA4* (G: 85±5 
wt.%).  
          
Figure 4. Gel content (G, A) and representative wet-state stress-compression curves (B) of samples 
MA25* (black), HA2* (grey) and HA4* (blue). *p<0.05 is considered significant (n=3).  
 
 
Interestingly, despite the lower gel content in HA-based compared to methacrylated 
networks, samples HA* could still display decreased mass loss and induce increased 
reduction of MMP activity, further confirming the effect of covalently-coupled HA 
adducts on to the collagen backbone. In line with the gel content data, the compression 
modulus (Figure 4 B) proved to be significantly affected by the hydrogel formulation, 
so that sample MA25* showed significantly higher compressive modulus (Ec: 128±17 
kPa) with respect to samples HA2* (Ec: 81±10 Pa) and HA4* (Ec: 72±16 kPa).  
HA derivatives are known to display radical scavenging functionality [71], 
suggesting that the presence of HA adducts in the methacrylated collagen precursor 
impacts on the half-life of UV-generated radicals, crosslinking reaction kinetics and 
network crosslink density. This hypothesis is likely to explain the trends in gel content 
across the different formulations, since decreased gel content and compression 
modulus were observed in HA-bearing compared to methacrylated samples. The 
indirectly-observed radical scavenging functionality of HA-bearing hydrogels could 
also play a major role in controlling the excessive upregulation of reactive oxygen 
species found in e.g. chronic wounds, providing an additional capability in controlling 
inflammation.   
 
3.6 In vitro cytotoxicity  
The potential use of the HA-conjugated collagen hydrogels in biological system was 
evaluated by investigating the cellular response of osteosarcoma cells when cultured 
in direct contact with the material. Cell metabolism and viability were measured by 
Alamar blue assay at day 4 and 7 of cell culture (Figure 5), and exemplarily confirmed 
via live /dead staining on cells seeded on HA-conjugated collagen network HA4* 
following 4-day culture (Figure 6).  
At day 4, the highest and lowest cell viability were recorded (via Alamar blue assay) 
in cells cultured onto either tissue culture plastic (TCP) or native collagen, whilst 
intermediate viability levels were seen in cells cultured with samples MA25*, HA2* and 
HA4* (Figure 5). No significant difference in cell viability was observed among the 
three UV-cured sample groups compared to the TCP group, whilst all of them were 
found to display increased cellular tolerance with respect to the sample of native 
collagen. At day 7, the highest cellular viability was measured via Alamar blue assay 
on cells cultured onto both TCP control and MA25* sample, with no statistical 
difference between them. Similar trends were also recorded in cells cultured onto 
native collagen control as well as onto samples of HA2* and HA4*, although respective 
cell viability proved to be significantly lower than the one recorded in TCP and MA25* 
groups. 
 
Figure 5. Alamar blue assay carried out with G292 osteosarcoma cells over 7 days. Cells were cultured 
on to either tissue culture plastic (black) and native collagen (grey) controls or samples of MA25* (light 
grey), HA2* (black, sparse patterned) and HA4* (grey, sparse patterned). *** indicates significantly-
different means with respect to the other means at each specific time point (p<0.001, n=6).  
 
Interestingly, sample MA25* seemed to induce a similar level of cellular proliferation 
and metabolism in comparison to the TCP control and in contrast to HA-conjugated 
collagen networks; this result may be due to the increased mechanical strength of 
hydrogel MA25* with respect to hydrogels HA2* and HA4*. Overall, these cell culture 
results successfully proved the high tolerability of all hydrogels tested in this study with 
G292 osteosarcoma cells.  
In agreement with the results obtained via Alamar blue assay, no hydrogel-induced 
toxic response was confirmed via live/dead staining of G292 cells following 4-day 
culture onto sample HA4*. In contrast to the positive control confirming the presence 
of dead (red) cells (Figure 6 A), only vital (green) cells were indeed detected in 
samples HA4* (Figure 6 C-D), as in the case of the negative control (Figure 6 B).  
Many reports suggested that soluble HA derivatives exhibit cytotoxicity against 
several cell lines such as human fibroblast, leukaemia and cancer cells [72-75]. This 
finding was not observed in this study as high cell viability was observed following 
7-day culture onto HA-bearing collagen hydrogels with respect to native collagen 
controls. This observation further supports the use of HA-coupled rather than 
HA-loaded systems for the prolonged and localised regulation of upregulated MMPs. 
 
 
 Figure 6. Typical live /dead staining of G292 osteosarcoma cells following 4-day culture. (A) and (B) 
show the positive and negative controls at day 4 of cell culture, respectively. (C) and (D) describe the 
live /dead staining of G292 cells following 4-day seeding on hydrogel HA4* at the magnification of ×10 
and ×20, respectively.  
 
 
4. Conclusions 
The synthesis of a HA-methacrylated collagen conjugate was successfully 
demonstrated for the development of soluble factor-free hydrogel photonetworks with 
integrated MMP-regulating capability. Sequential covalent coupling of methacrylate 
and HA adducts to collagen was selectively accomplished by independently targeting 
amino and carboxyl groups, respectively. In this way, the hydrogel MMP-regulating 
capability could be controlled independently of the collagen network crosslink density. 
Amination of carboxyl groups via grafting reaction with EDA proved successful to 
indirectly quantify the degree of HA-mediated collagen functionalisation by both TNBS 
and Ninhydrin assays. Resulting HA-conjugated collagen samples maintained their 
unique triple helical structure, although at a lower extent with respect to methacrylated 
samples. The hydrogel-induced reduction in activities of both MMP-3 and MMP-9 
demonstrated the MMP-modulating capability induced by the covalent 
functionalisation of the collagen backbone with MMP-chelating HA adducts, whereby 
the inherent MMP substrate specificity was observed to play a role. Increased 
enzymatic stability and decreased compressive modulus were measured in HA-
conjugated compared to methacrylated hydrogel networks, in agreement with the 
presence of covalently-coupled HA adducts. Such materials were also shown to be 
cell friendly when cultured with G292 osteosarcoma cells. The versatility of this HA-
methacrylated collagen conjugate has great potential in bypassing the well-known 
clinical problems associated with chelating agent-loaded medical products and 
provides a novel solution for the device-based modulation of MMP overexpression in 
a variety of diseases.  
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